Biological Characterization of Gene Response to Insulin-Induced Hypoglycemia in Mouse Retina. by Emery, M. et al.
RESEARCH ARTICLE
Biological Characterization of Gene Response
to Insulin-Induced Hypoglycemia in Mouse
Retina
Martine Emery1, Natacha Nanchen1, Frédéric Preitner2, Mark Ibberson3,
Raphaël Roduit1,4*
1 IRO, Institute for Research in Ophthalmology, Sion, Switzerland, 2 Mouse Metabolic Evaluation Facility,
Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland, 3 Vital-IT Group, Swiss
Institute of Bioinformatics, University of Lausanne, Lausanne, Switzerland, 4 Department of Ophthalmology,
University of Lausanne, Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, Lausanne, Switzerland
* raphael.roduit@unil.ch
Abstract
Glucose is the most important metabolic substrate of the retina and maintenance of normo-
glycemia is an essential challenge for diabetic patients. Chronic, exaggerated, glycemic
excursions could lead to cardiovascular diseases, nephropathy, neuropathy and retinopa-
thy. We recently showed that hypoglycemia induced retinal cell death in mouse via caspase
3 activation and glutathione (GSH) decrease. Ex vivo experiments in 661W photoreceptor
cells confirmed the low-glucose induction of death via superoxide production and activation
of caspase 3, which was concomitant with a decrease of GSH content. We evaluate herein
retinal gene expression 4 h and 48 h after insulin-induced hypoglycemia. Microarray analy-
sis demonstrated clusters of genes whose expression was modified by hypoglycemia and
we discuss the potential implication of those genes in retinal cell death. In addition, we iden-
tify by gene set enrichment analysis, three important pathways, including lysosomal func-
tion, GSHmetabolism and apoptotic pathways. Then we tested the effect of recurrent
hypoglycemia (three successive 4h periods of hypoglycemia spaced by 48 h recovery) on
retinal cell death. Interestingly, exposure to multiple hypoglycemic events prevented GSH
decrease and retinal cell death, or adapted the retina to external stress by restoring GSH
level comparable to control situation. We hypothesize that scavenger GSH is a key com-
pound in this apoptotic process, and maintaining “normal”GSH level, as well as a strict gly-
cemic control, represents a therapeutic challenge in order to avoid side effects of diabetes,
especially diabetic retinopathy.
Introduction
Microvascular complications leading to nephropathy, cardiovascular diseases, neuropathy and
retinopathy are serious consequences of both type I and II diabetes [1]. Diabetic retinopathy is
generally linked to hyperglycemia [2], but recently we [3–5] and other [6–10] have described
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the key role of hypoglycemia in retinal visual dysfunction and cell death. There are several dif-
ferent causes of hypoglycemia, including inappropriate diet, irregular physical activity and
unsuitable insulin treatment of diabetes. This latter, called iatrogenic hypoglycemia, causes
cerebral edema leading to coma, even mortality, in people with type I diabetes and in many
with advanced type II diabetes [11]. In addition, retinopathy of prematurity may also be the
consequence of hypoglycemic periods that alter brain (and retina) development [12]. Very little
is known about the real effect of chronic or acute hypoglycemic event on visual functions.
The majority of studies have focused on cellular models showing that low glucose condi-
tions reduced viability of all retinal cell types in a mixed primary cell culture [13], while aglyce-
mic conditions forced isolated chick retinas to metabolize and use lactate to preserve ATP
levels and retinal neuronal cell death [14]. Diverse in vivo studies showed that chronic moder-
ate hypoglycemia observed in glucagon receptor-deficient mice (Gcgr-/-) led to loss of vision
and possible retinal degeneration [6], long-term exposure of this mouse model to carbohydrate
diet normalized glycemia and partially restored retinal function [9]. In human, acute effect of
hypoglycemia involve principally central vision [8]. More generally, Punzo et al. recently sug-
gested that cone death in retinitis pigmentosa could be, at least in part, the result of the starva-
tion of cones via the insulin/mTOR pathway [7]. We previously showed that insulin-induced
hypoglycemia led to retinal cell death, possibly through a modification of glutathione (GSH)
metabolism that alters GSH level of the cell [3]. We further detailed the mechanism of apopto-
sis involved in this acute hypoglycemic mouse model and described the role of Bcl-2/Bax in the
process. Furthermore, we define an important role of autophagy in the protection of low glu-
cose-induced 661W photoreceptor cell death [4].
Strict monitoring and maintenance of normoglycemia is a key element for diabetic patients
in order to minimize both hyper- and hypoglycemic events. Avoiding multiple hypoglycemic
events is even more critical because recurrent episodes of hypoglycemia lead to hypoglycemia-
associated autonomic failure (HAAF). In this regard, repeated hypoglycemia leads to a defect
in hypoglycemia-induced activation of counter-regulatory mechanisms (namely, an attenua-
tion of the normal epinephrine response to hypoglycemia, whilst insulin is not reduced and
glucagon not increased by low glucose). Repeated hypoglycemia also causes hypoglycemia
unawareness, which leads to the degradation of glycemic control by patients. Thus, in this
vicious cycle HAAF increases the risk of recurrent and severe hypoglycemic events because of
the inability to recognize hypoglycemia [15, 16].
In this study, we sought to characterize the changes in gene expression in the whole retina
of mice undergoing acute hypoglycemia during 4 hours with a recovery time ranging from 4
hours to 2 days. We performed Affymetrix microarray analysis in mouse retinas isolated after a
hyperinsulinemic/hypoglycemic or hyperinsulinemic/euglycemic clamp. We highlighted
diverse pathways involved in apoptosis, lysosomes and glutathione metabolism. Moreover, we
performed multiple hyperinsulinemic/hypoglycemic or hyperinsulinemic/euglycemic clamps
to test whether this treatment, often called preconditioning, could more strongly impact or
protect retinal cell death. Interestingly, no cell death was observed after multiple successive
clamps, suggesting a protective effect or an adaptation to hypoglycemic events.
Methods
Mouse line
This study adhered to the Association for Research in Vision and Ophthalmology (ARVO)
statement for the use of animals in ophthalmic and vision research and was approved by the
Veterinary service of the State of Valais (Switzerland). Three month-old C57BL/6J female mice
were purchased from Charles River Laboratories (Les Oncins, France). Animals were kept at
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23°C in a 12-h light/12-h dark cycle (7am-7pm) with unlimited access to chow diet (3436, Pro-
vimi Kliba AG, Kaiseraugst, Switzerland) and water in vented, filtered M.I.C.E. cages (Animal
Care Systems Inc, CO, USA) in the housing room of the Mouse Metabolic Facility, Center for
Integrative Genomics, University of Lausanne, Lausanne, Switzerland) with conventional-
experimental health status (no MHV).
Hyperinsulinemic clamps
Hyperinsulinemic clamps were performed as previously described [3] in 25–30g mice. An
indwelling catheter (Becton Dickinson AG, Basel, Switzerland) was inserted into the femoral
vein in isoflurane-anesthetized mice. Pediatric Dafalgan was administered in drinking water
(2mg/ml) 1 day prior, and 2 days post-operation. Mice were allowed to recover for 7 days, after
which they had recovered 98–110% of their pre-operative body weight.
Experiment 1 (single clamps): After a 5-h fast (7:30–12:30am), awake and freely moving
mice were randomized and subjected to 4 h of either a hyperinsulinemic/hypoglycemic
(sHypo, n = 16) or hyperinsulinemic/euglycemic (sEugly, n = 18) clamp as described [17]. The
clamp was initiated by prime-infusion of human insulin (Actrapid, Novo Nordisk, Denmark,
18 mU/kg/min), and 50% glucose was infused at variable rates and adjusted to clamp plasma
glucose around 2mM (sHypo) or 6mM (sEugly) as measured by glucometers on 2ul blood sam-
ples (Ascensia Breeze2, Bayer Healthcare, Switzerland) every 10 min during the stabilization
period and every 20 minutes thereafter in order to minimize bleed volume (total 55–60ul).
After 4 hours of clamp, insulin infusion was stopped and glucose infusion was maintained
until the return to euglycemia was warranted in all groups. Mice were then returned to their
cages with free access to food and water. Mice were sacrificed 4 or 48 h post-clamp by CO2
inhalation followed by decapitation and isolated retinas were used to prepare mRNAs for
microarray and others analysis (S1 Table).
Experiment 2 (multiple and single clamps): After a 5-h fast (7:30–12:30am), awake and
freely moving mice were randomized and subjected to three consecutive clamps performed in
the same mice as described above, with a 2 days recovery after each hyperinsulinemic/hypogly-
cemic (mHypo, n = 6) or hyperinsulinemic/euglycemic (mEugly, n = 4) clamps. During the
last clamp, two additional groups of mice were subjected to either a single hyperinsulinemic/
hypoglycemic (sHypo, n = 6) or a single hyperinsulinemic/euglycemic (sEugly, n = 4) clamps.
All mice were sacrificed 48 h post-clamp and isolated retinas were used to prepare retinal flat-
mount for TUNEL assay, mRNAs for qPCR analysis, protein lysates for GSH measurement. In
addition whole eyes were used for immunohistochemistry analysis (S2 Table).
Microarray analysis
RNA samples isolated from retina, 4 and 48 h after the end of the clamp (3 samples per condi-
tion; 12 samples total), were diluted to 100 ng/ μl and used to perform the target preparation
using the Whole Transcript Sense Target Labeling Protocol procedure (Affymetrix, High Wyc-
ombe, UK). 5.5 μg of each fragmented cDNA were end-labeled with biotin and hybridized to a
GeneChip Mouse Gene 1.0 ST array (Affymetrix), then processed and scanned according to
standard procedures. Background subtraction, quantile normalization and probeset summari-
zation was performed with the Affymetrix Power Tools command line tool, using the RNA
method [18]. All subsequent statistical analyses were performed using R (http://www.R-
project.org) and Bioconductor packages (http://www.Bioconductor.org). Differential hybrid-
ized features were identified using Bayes moderated t statistics with the Bioconductor package
"limma" [19]. Genes with a p-value< = 0.01 (unadjusted) were considered here as differentially
expressed. Hierarchical clustering of samples and differentially expressed genes was performed
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on matrices of sample or gene distances (Euclidean), using Pearson correlation with average-
linkage clustering. Heatmaps were generated using the gplots package of Bioconductor. All
gene expression data is MIAME compliant and the raw data has been deposited in a MIAME
compliant database (GEO accession numbers GSE67523)
Gene Set Enrichment Analysis (GSEA)
Pathway analysis was performed against mouse MSigDB canonical pathways (V3) using the
GSEA algorithm [20]. Genes were ranked by fold change difference (high to low) between
hypoglycemia and euglycemia at 48 hours prior to perfoming GSEA. The resulting p values
were corrected for multiple comparisons with Benjamini-Hochberg correction in R. The
adjusted p-value was used to filter the pathways enriched for up- and down-regulated genes:
pathways enriched with an adjusted p value< = 0.05 were kept for further analysis.
Terminal dUTP Nick End-Labeling (TUNEL) of fragmented DNA
In situ cell death detection was performed 48 h after hypoglycemic clamp, by TUNEL technol-
ogy as described by the manufacturer (Roche Applied Science, Rotkreus, Switzerland) and
detailed in Hamann S. et al. [10]. For each condition, apoptotic cells were visualized under a
fluorescence microscope (Leica) using appropriate filters.
Immunostaining
Enucleated eyes were fixed in 4% PFA/PBS for 45 min, followed by cryoprotection in 30%
sucrose/PBS. Ten μm-embedded frozen sections were further processed for immunohis-
tochemistry. Briefly, frozen retina sections were blocked in PBS with 3% normal goat serum
(Sigma, Buchs, Switzerland) and 0.2% Triton X-100 (Sigma) for 1 h at RT and then incubated
with antibodies against cleaved Caspase3 (dilution 1/500, Cell Signaling Technology, Inc. Dan-
vers, MA, USA), GPX3 (dilution 1/50, Abcam, Cambridge, MA, USA), GSTO-1 (dilution 1/
200, Santa-Cruz Biotechnology, Dallas, TX, USA), FIBULIN-1 (dilution 1/200, Santa-Cruz
Biotechnology, Dallas, TX, USA) and VERSICAN (dilution 1/100, Abcam, Cambridge, MA,
USA) in the blocking buffer overnight at 4°C. Thereafter, sections were incubated again in
blocking buffer for 30 min at RT before being incubated for 1 h at RT with FITC Alexa-Fluor
594 goat anti-rabbit antibody or with FITC Alexa-Fluor 594 sheep anti-goat antibody (dilution
1/2’000,) depending of primary antibody used. Incubation with secondary antibody alone was
used as a negative control. Tissue sections were counterstained with DAPI to identify retinal
cell layers.
GSH content analysis
GSH content was measured as previously described [3], briefly twenty μg of total protein
lysates, isolated from the retina of single hypoglycemic (sHypo), multiple hypoglycemic
(mHypo), single euglycemic (sEugly) and multiple euglycemic (mEugly) mice, sacrificed 48 h
post-clamp, were used for the measurement of GSH retinal content. The GSH content was
measured with Bioxytech GSH/GSSG-412 kit (#21040; OxisResearch, Beverly Hills, CA, USA)
according to the protocol.
RT-PCR analysis
Eight hundred ng of total RNA in a 20 μl reaction were used for cDNA synthesis using oligo
(dT)18 according to the manufacturer’s procedure (First strand cDNA synthesis kit for
RT-PCR, Roche Applied Science, Rotkreuz, Switzerland). The equivalent of 2 to 20 ng original
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total RNA was used for quantitative PCR amplification using the 2 x brilliant SYBR Green
QPCRMaster Mix (Stratagene) and 0.5 μM forward and reverse primer pair, designed to span
an intron of the target gene. Real-time PCR was performed in multiple replicate in the
Mx3000PTM system (Stratagene) with conditions previously described [3].
Statistical Analysis
All results were expressed as means ± SEM of the indicated number of experiments. Data were
statistically analyzed using Prism 6.0 software. We first tested each group of data for distribu-
tion normality using Shapiro-Wilk tests. In case of normal distribution, we used a Welch’s
ANOVA test (one-way ANOVA with unequal variances) followed by a post-hoc Tukey-Kra-
mer test to compare the different treatments. When the distribution was not normal, we used a
Kruskal-Wallis test (non-parametric analogue of the one-way ANOVA) to compare the differ-
ent treatments. p< 0.05 was chosen as the threshold for statistical significance.
Results
Insulin-induced hypoglycemia regulates gene expression
We performed a single hyperinsulinemic/hypoglycemic clamp on 18 different mice after a
short period of fasting; hyperinsulinemic/euglycemic clamp was used as controls (16 mice).
Glycemia before the clamp was similar in both groups of mice and clearly different during the
4-hours of the clamp (Fig 1A). We isolated three retinas from each group of mice, 4 h and 48 h
after the end of the clamp, and extracted mRNA for microarray analysis. Fig 1B shows a heat
map with the visualization of four different clusters of genes up-regulated (cluster 1) or down-
regulated (cluster 2) 4 h after the clamp, up-regulated (cluster 3) or down-regulated (cluster 4)
48 h after the clamp. Tables 1 and 2 show the top 15 genes up- or down-regulated in each
cluster.
We performed a sensitive pathway analysis (Gene Set Enrichment Analysis: GSEA [20])
comparing hypoglycemia vs euglycemia 48 h after a single clamp and we highlighted three
important pathways, including KEGG lysosomes (Fig 2A), KEGG GSHmetabolism (Fig 2B)
and REACTOME-apoptosis (Fig 2C). Moreover, we were able to point out several glycopro-
teins (Fibulin1, Versican, Fibromodulin) linked to the extracellular matrix (ECM), many crys-
tallins and few solute carriers (Slc26a4, Slc6a13) whose expression was modified by
hypoglycemia.
To confirm that genes showing an increase at mRNA level (Table 2), also showed an
increase at protein level we performed several immunostaining of proteins involved in GHS
metabolism (GPX3 and GSTO-1) and in establishment of the extracellular matrix (VERSICAN
and FIBULIN-1). Fig 3 shows an increased immunostaining of GPX3 and GSTO-1 principally
in photoreceptor outer segment (POS), inner plexiform layer (IPL) and ganglion cell layer
(GCL). Proteins of the extracellular matrix, VERSICAN and FIBULIN-1 show similar staining
with a significant increase of FBULIN-1 in POS and IPL, while VERSICAN staining is princi-
pally increased in GCL (Fig 3A and 3B).
Multiple successive acute hypoglycemias did not induce retinal cell
death in mouse in comparison with single acute hypoglycemia
We recently showed that acute (4 h) hypoglycemia strongly induces retinal cell death in mice.
In order to analyze the effect of multiple successive hypoglycemia on mouse retina, we per-
formed three hyperinsulinemic/hypoglycemic clamps (mHypo), spaced by 48 h each. We per-
formed three similar hyperinsulinemic/euglycemic clamps (mEugly) as control group. In
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Fig 1. Identification of differentially expressed genes during hyperinsulinemic/hypoglycemic clamp.
A) Mouse plasma glucose concentration before, during and after the clamp. *p<0.0001 Hypo (n = 18) vs.
Eugly (n = 16). B) Heatmap of significantly differentially regulated genes (p0.01) at 4 hours and 48 hours,
showing mean normalized intensities (n = 3) at each time-point and condition.
doi:10.1371/journal.pone.0150266.g001
Hypoglycemia and Microarray Analysis
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parallel with the last clamp, we added two groups including a single hyperinsulinemic/hypogly-
cemic clamp (sHypo) as positive control and a single hyperinsulinemic/euglycemic clamp
(sEugly) as negative control. Both euglycemic groups (mEugly and sEugly) of mice received
comparable amounts of insulin but were injected with glucose in order to maintain normal gly-
cemia. Comparison of these four groups allowed us to analyze the effect of multiple successive
hypoglycemias in mice. We monitored glycemia throughout all clamps (Fig 4A). Glucose infu-
sion, necessary to maintain either the hypoglycemia at 2.2 mM or the euglycemia at 5–6 mM,
is shown in fig 4B. Glycemia before the clamp was similar for both groups, while a significant
expected difference in glycemia was observed during the clamp (Fig 4C). We observed that
glucose infusion rate necessary to maintain hypoglycemia around 2.2 to 2.4mM was more
important for the second and third clamp in comparison to the first clamp or to the single
Table 1. Top 15 genes up/down-regulated by hypoglycemia ranked by fold change (FC) tested 4 hours after the hyperinsulinemic/hypoglycemic
clamp.
Symbol Gene Name FC p value Gene ID Aff. ID
Top 15 genes up-regulated by hypoglycemia ranked by fold change (FC)
Kif4 Kinesin family member 4 3.4 2.5E-6 16571 10601011
Gas5 Growth arrest speciﬁc 5 2.2 8.5E-5 14455 10351039
Etnppl Ethanolamine-Phosphate Phospho-Lyase 2.0 6.1E-5 71760 10496077
Selenbp1 Selenium binding protein 1 1.8 1.1E-3 20341 10494114
Tc2n Tandem C2 domains, nuclear 1.8 1.8E-3 74413 10402195
Mt2 Metallothionein 2 1.7 2.2E-4 17750 10574023
Actr6 ARP6 actin-related protein 6 1.7 8.5E-5 67019 10371830
Folh1 Folate hydrolase 1.7 6.5E-4 53320 10565401
Pdcd5 Programmed cell death 5 1.6 2.7E-3 56330 10360983
Ccne2 Cyclin E2 1.6 5.1E-4 12448 10503264
Fkbp5 FK506 binding protein 5 1.6 5.0E-4 14229 10449452
Rbm3 RNA binding motif protein 3 1.6 1.9E-5 19652 10556113
Selenbp2 Selenium binding protein 2 1.6 2.3E-4 20342 10494085
Eif3e Eukariotic translation initiation factor 3, subunit E 1.6 1.9E-3 16341 10428398
Rpl5 Ribosomal protein L5 1.6 9.0E-3 100503670 10459669
Top 15 genes down-regulated by hypoglycemia ranked by fold change (FC)
Fbln1 Fibulin 1 2.0 8.1E-2 14114 10425945
Cryaa Crystallin, alpha A 1.9 6.0E-2 12954 10443830
Dct Dopachrome tautomerase 1.7 8.8E-3 13190 10422249
Crygs Crystallin, gamma S 1.7 2.9E-3 12970 10438668
Olfr715 Olfactory receptor 715 1.6 6.6E-3 258776 10566624
Slc26a4 Solute carrier family 26, member 4 1.6 7.0E-2 23985 10399854
Ldlr Low density lipoprotein receptor 1.6 1.6E-5 16835 10583732
Olfr767 Olfactory receptor 767 1.6 1.3E-4 258315 10373610
Gja1 Gap junction protein, alpha 1 1.6 1.2E-1 14609 10363173
Cryba4 Crystallin, beta A4 1.6 6.9E-4 12959 10532517
Tek Endothelial-speciﬁc receptor tyrosine kinase 1.6 4.0E-4 21687 10505954
Fmod Fibromodulin 1.6 3.4E-2 14264 10349947
Tmem132b Transmembrane protein 132B 1.6 5.0E-4 208151 10525923
Pltp Phospholipid transfer protein 1.5 1.0E-2 18830 10489569
Cryba1 Crystallin, beta A1 1.5 1.7E-1 12957 10388707
FC (Fold Change) in gene expression 4h after the hypoglycemic clamp, euglycemic clamp is used as control
doi:10.1371/journal.pone.0150266.t001
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hyperinsulinemic/hypoglycemic clamp (S1 Fig). Indeed, we injected less glucose during the
first (23.167 ± 4,74 mgKg−1min−1) and the single clamp (22.25 ± 6.8 mgKg−1min−1) in
comparison to the second (37.5 ± 1.87 mgKg−1min−1) and the third clamp (36.6 ± 0.99
mgKg−1min−1).
We then isolated flat-mount retinas 48 h after the clamp, and performed TUNEL staining
in each group. Fig 5A shows TUNEL-positive cells only in the retina from mice, which experi-
enced a single hypoglycemic event. Very few positive cells, if any, were observed in multiple
successive hypoglycemic (mHypo) and in both euglycemic conditions (mEugly and sEugly)
and control sham-operated mice (data not shown).
Apoptosis is often associated with caspase 3 activity in diverse models, including hyperin-
sulinemic/hypoglycemic clamp (sHypo) that we previously described [3]. Interestingly,
Table 2. Top 15 genes up/down-regulated by hypoglycemia ranked by fold change (FC) tested 48 hours after the hyperinsulinemic/hypoglycemic
clamp.
Symbol Gene Name FC p Value Gene ID Aff. ID
Top 15 genes up-regulated by hypoglycemia ranked by fold change (FC)
Gpx3 Glutathione peroxidase 3 4.8 1.2E-2 14778 10376201
Fbln1 Fibulin 1 4.5 4.9E-3 14114 10425945
Slc26a4 Solute carrier family 26, member 4 4.3 1.8E-3 23985 10399854
Klk1b22 Kallikrein 1-related peptidase b22 4.0 5.0E-2 13646 10552594
Penk Preproenkephalin 3.8 2.0E-2 18619 10511363
Gja1 Gap junction protein, alpha 1 3.4 2.8E-3 14609 10363173
Vcan Versican 3.0 1.4E-2 13003 10410931
Hba-a2 Hemoglobin alpha, adult chain2 2.7 1.2E-4 110257 10375058
Hba-a1 Hemoglobin alpha, adult chain 1 2.7 1.1E-4 15122 10375051
Atp1a2 ATPase, NA+/K+ transporting, alpha 2 polypeptide 2.6 3.7E-3 98660 10360270
Slc6a13 Solute carrier family 6, member 13 2.5 2.9E-3 14412 10541318
Serpina3n Serine peptidase inhibitor, clade A, member 3N 2.4 4.4E-4 20716 10398075
Fmod Fibromodulin 2.4 8.9E-3 14264 10349947
Krt5 Keratin 5 2.3 1.3E-3 110308 10432785
Optc Opticin 2.2 9.7E-3 269120 10357858
Top 15 genes down-regulated by hypoglycemia ranked by fold change (FC)
Gluld1 Glutamate-amoniase ligase (glutamine synthetase) 3.1 2.0E-1 266744 10345190
Crygd Crystallin, gamma D 2.6 4.1E-1 12967 10355191
Crygc Crystallin, gamma C 2.6 3.3E-1 12966 10355193
Crygb Crystallin, gamma B 2.4 3.3E-1 12965 10355199
Bfsp2 Beaded ﬁlament structural protein 2, phakinin 2.3 2.7E-1 107993 10596190
Bfsp1 Beaded ﬁlament structural protein 1, in lens-CP94 2.1 3.2E-1 12075 10488185
Lim2 Lens intrinsic membrane protein 2 1.7 2.0E-1 233187 10552398
Tgfb3 Transforming growth factor, beta 3 1.7 6.0E-2 21809 10430929
Mpv17 MpV17 mitochondrial inner membrane protein 1.7 1.3E-2 17527 10529091
Adam4 A disintegrin and metallopeptidase domain 4 1.7 9.0E-2 11498 10401320
Lctl Lactase-like 1.6 5.0E-2 235435 10586140
Nebl Nebulette 1.6 1.1E-1 74103 10480286
Psg29 Pregnancy-speciﬁc glycoprotein 29 1.6 3.0E-2 114872 10550424
Fabp5 Fatty acid binding protein 5, epidermal 1.6 2.5E-2 16592 10490838
Hspb1 Heat shock protein 1 1.6 3.1E-1 15507 10526410
FC (Fold Change) in gene expression 48h after the hypoglycemic clamp, euglycemic clamp is used as control
doi:10.1371/journal.pone.0150266.t002
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the same as no retinal cell death observed after three successive hypoglycemic events (Fig
5A), neither were we able to observe any Caspase 3 activation in those retinas. Fig 5B shows
positive cells in the ONL of mice suffering a single hypoglycemic event, while no positive
cells for cleaved caspase 3 were observed in the retina of the other groups of mice (mHypo,
mEugly and sEugly).
Fig 2. Heatmaps of selected pathways that were significantly enriched for hypoglycemia up-regulated genes at 48 hours identified by GSEA. A)
KEGG Lysosome pathway; B) KEGGGlutathione metabolism; C) REACTOME Apoptosis. The genes shown in the heatmaps are the leading edge subsets
(the enriched genes) from the GSEA analysis [20]. GSEA score plots are shown alongside the heatmaps: Here a score peak towards the left indicates
enrichment of pathway genes at the top of the list of genes ranked by fold-change. All three pathways shown were significantly enriched (corrected p-
value 1e-4) based on 10000 permutations.
doi:10.1371/journal.pone.0150266.g002
Hypoglycemia and Microarray Analysis
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Reduced glutathione (GSH) content played key role in cell death
We recently showed the key role of GSH in retinal cell death. Indeed, GSH metabolism is
altered as observed in pathway analysis (Fig 2B) and GSH content was decreased when mice
suffered a single hypoglycemic event (this study (Fig 6A) and [3]). When we tested the GSH
level in all groups of mice, we only observed, as expected, a marked decrease of GSH in mice
suffering a single hypoglycemia, while multiple successive hypoglycemic events did not alter
GSH content, or restore normal GSH level. Control groups, single and multiple euglycemia,
also showed no modification of GSH content (Fig 6A). Interestingly, we previously showed
that GSH metabolism is decreased during hypoglycemia, with both an increase of the glutathi-
one peroxidase 3 (Gpx3) and the glutathione S-transferase omega 1 (Gsto-1) expression either
in vivo during single hypoglycemia, and in 661W photoreceptor cells or in C57BL/6 isolated
retina cultured at low glucose concentration [3]. As expected and showed in fig 6B, we
observed an increase in the expression of Gsto-1 and Gpx3 expression only after a single hypo-
glycemia, while mRNA expression of Gsto-1 was not changed after multiple successive hypo-
glycemic clamps and neither was Gpx3 obviously decreased (Fig 6B).
Fig 3. Increase expression of proteins involved in GSHmetabolism and in the establisment of the
extracellular matrix. Immunostaining of GPX3 and GSTO-1 proteins (A), and VERSICAN and FIBULIN-1
(B) in the retina of mice submitted to a hypoglycemic (Hypo) or euglycemic (Eugly) clamp (white arrows
showed accumulation of proteins of interest). This experiment is representative of 3 retinas for each group.
doi:10.1371/journal.pone.0150266.g003
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Fig 4. Insulin-inducedmultiple and single hypoglycemia in C57BL/6 mouse. A) Graphic representation
of plasma glucose levels during hyperinsulinemic clamps. Three successive hypoglycemic (mHypo; n = 6)
and euglycemic (mEugly; n = 4) clamps (right part of the graph) spaced by 48 h were performed; during the
last clamp, single hypoglycemic (sHypo; n = 6) and euglycemic (sEugly; n = 4) clamps were performed
additionally (left part of the graph). B) Graphic representation of glucose infusion rates during all
hyperinsulinemic/hypoglycemic clamps (black circle for mHypo and black square for sHypo) and the control
hyperinsulinemic/euglycemic clamp (white circle for mEugly and white square for sEugly). Multiple clamps
are showed in the left part of the graph, while single clamps are showed in the right par of the graph C) Mouse
characteristics before and during the clamp. *p<0.005 Hypo vs. Eugly.
doi:10.1371/journal.pone.0150266.g004
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Discussion
The sequential microarray analysis of mice suffering hypoglycemic events revealed multiple
modifications in retinal gene expression, either 4 h or 48 h after the clamp. Interestingly, we
highlight broad changes in many different pathways, including GSH metabolism, lysosomal
regulation and apoptosis. Indeed, we confirmed our previous results showing the key role of
GSH in low glucose-induced retinal cell death [3]. We have previously shown by qPCR, the
increase of Gpx3 (the top gene up-regulated by hypoglycemia; fold change = 4.8), and Gsto-1
(up-regulated by hypoglycemia; fold change = 1.9) in comparison with euglycemic control situ-
ation. Genetic expression of both genes was also increased when isolated mouse retinas were
cultured 48 h at low glucose condition (Gpx3, fold change = 5 and Gsto-1, fold change = 1.5)
[3]. Interestingly, microarray analysis also pointed out the down-regulation of the glutamine
synthetase (Gluld1), also called Legsin, a protein highly expressed in lens with strong similarity
to glutamine synthetase type I (top gene down-regulated by hypoglycemia; fold change = 3.1).
The role of this protein, as well as its expression pattern in retina, is controversial. Whereas
Barragan et al. suggest a potential role of LEGSIN (LGS) in glutamate uptake and transport
[21], Grassi et al. rule out any involvement of the splice variant Lgs_ ν2 in glutamine biosynthe-
sis. Grassi et al. further claim that LGS is preferentially (if not exclusively) expressed in the lens
Fig 5. Multiple successive hypoglycemias did not exacerbate cell death in mouse retina but protect against retinal apoptosis. A) Flat-mounted
retinas were isolated 48 h after the clamp, stained for cell death by TUNEL assay and DAPI counter coloration was performed. White arrows show TUNEL
positive cells in single hypoglycemic condition (sHypo) while no TUNEL positive cells were detected when multiple successive hypoglycemia (mHypo) was
applied. Control situation with multiple euglycemia (mEugly) or single euglycemia (sEugly) showed, as expected, no TUNEL positive cells. Results were
representative of two (sEugly/mEugly) to three (sHypo/mHypo) observed flat-mount retinas for each group. B) Cleaved Caspase 3 antibody showed positive
cells (white arrow) in the outer nuclear (ONL) of the hypoglycemic mice retina, while no positive cells were observed in all other conditions. Counterstaining
with DAPI was performed to identify the retinal cell layers. Results were representative of four (sEugly), one (mEugly), four (sHypo) or two (mHypo) observed
retinas for each group.
doi:10.1371/journal.pone.0150266.g005
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[22]. As we were able to measure LGS expression in retinal mRNA preparations, which are
essentially devoid of contamination by, lens mRNA, (S2 Fig), we cannot completely exclude a
bona fide expression of Lgs (or another splice variant of Lgs) in the retina. In line with a non-
exclusive retinal expression of Lgs, Nakatsugawa et al., recently showed that Lgs expression is
not restricted to the lens but also found in liver, placenta, skeletal muscle and pancreas. In this
latter study the authors also described a novel splice variant of Lgs (Lgs_ν4) expressed in lung
[23].
Overall, our present and previous studies provide several lines of evidence supporting a key
role of GSH in hypoglycemia-induced cell death, including the up-regulation of Gpx3 and
Gsto-1 expression at both mRNA and protein levels (see [3] and Fig 6), the alteration in GSH
metabolism suggested by the GSAE analysis (Fig 2) and the demonstration of a causal role of
GSH content modulation on retinal cell death [3]. Accordingly, recurrent hypoglycemia leads
to the restoration of “normal” GSH level, which correlates with an absence of retinal cell death
(Fig 5).
In addition, in our last study we deciphered the mechanism of apoptosis induced by low glu-
cose and suggested a defect of fusion between lysosomes and autophagosomes, probably due to
a significant decrease of Lamp2a expression, that led to autophagy inhibition and cell death
[4]. Even if Lamp2a expression was not altered in the microarray analysis, we cannot exclude a
role of this gene in the process. Moreover, in this study, microarray analysis emphasized both
apoptotic and lysosomal pathways that are altered by hypoglycemia.
Microarray analysis suggests a potential role of many proteins that are highly glycosylated
and linked to the extracellular matrix (ECM), including glycoproteins (Fibulin1:Fbln1) and
proteoglycans (Versican:Vcan, Fibromodulin:Fmod). We observed a decrease of Fbln1 and
Fmod 4 h after the clamp, but an increase of both gene expressions as well as an increase of
Vcan expression 48 h after the clamp. Both FBLN-1 and VSC proteins were also increase in
mice undergoing hypoglycemia. Whereas no specific role for Fbln1 has been described so far in
Fig 6. GSH homeostasis wasmodulated in the retina of mice suffered single hypoglycemia but not after multiple successive hypoglycemic
events. A) GSH content was measured in protein lysates obtained from retina of single euglycemic (sEugly: white inverted triangle), multiple euglycemic
(mEugly: white triangle), single hypoglycemic (sHypo: black square) and multiple hypoglycemic (mHypo: black circle) mice. Results were expressed as
percent of sEugly and as mean ± SEM of 2 to 4 samples. *p<0.01 sHypo vs. sEugly. B) We tested the expression of two genes, Gpx3 and Gsto1, in the retina
of hypoglycemic and euglycemic animals 48 h after the clamp. We were able to show, by RT-qPCR, the induction of both genes in single hypoglycemic
conditions, but not after multiple successive hypoglycemic or euglycemic. RL8 (ribosomal protein L8) was used as internal control to normalize RNA
expression and results are expressed as percent of respective control (sEugly, mEugly) and as mean ± SEM of 3 retinas, *p<0.04.
doi:10.1371/journal.pone.0150266.g006
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the retina, Fibulin2 (Fbln2) has been implicated in retinal detachment observed in diabetic reti-
nopathy, retinopathy of prematurity and other retinal complications [24]. Fibulin3 (Fbln3) has
also been associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy
[25]. Interestingly, Fbln1 has a high affinity for Vcan (also increased in the microarray analy-
sis), this latter protein interacting also with numerous other ECM components such as hyalur-
onan, type I collagen, fibrillin-1, fibronectin and chemokines [26]. The retinal role of the
proteoglycan Fmod is not clear yet, but it has been described to promote angiogenic environ-
ment, probably via transforming growth factor beta 1 (TGFb1) secretion; it has also been linked
to an enhancement of vascular sprouting during normal retinal development [27]. Abnormal
expression of these glycosylated proteins may affect the structure and the neovascularization of
the retina via modification of ECM of the retina.
Crystallins are water soluble proteins essentially found in the lens and cornea of the eye. We
observed a decrease of alphaA, gammaS, betaA4 and betaA1 4 h after the hypoglycemic clamp
(Table 1), while crystallins gammaB, gammaC and gammaD were down regulated 48 h after
the clamp (Table 2). Although the decrease of these genes, observed 48h after the clamp, were
not significantly differentially expressed according to our criteria, the fact that we see several of
them down regulate, 4h after the clamp and few others 48h after the clamp, suggests a possible
role for these proteins in the process. Alpha A crystallin has already been implicated in numer-
ous cellular processes, including oxidative stress, neuroprotection, survival and cell death path-
ways [10, 28], but little is known about the role of the other crystallins that could not only be
restricted to the lens but also implicated in a whole gene network in the mouse retina [29].
Microarray analysis also highlights the decrease in the expression of two solute carriers,
Slc26a4, (reduced 4 h and 48 h after the clamp) and Slc6a13, (reduced 48 h after the clamp).
Slc26 genes family is multifunctional anion exchangers while Slc6 genes family have been
described as neurotransmitter symporters, but nothing is known about their potential role in
the retina. Even if very recently, another solute carrier, Slc24a1 has been implicated in congeni-
tal stationary night blindness [30], further experiments will be needed to clearly implicate
those transporters in hypoglycemic-induced retinal cell death and diabetic retinopathy.
When we tested the effect of recurrent hypoglycemia (three successive hypoglycemia,
spaced by 48 h), we first observed the need of higher glucose infusion rate in the second and
third clamps in comparison to the first and to a single hypoglycemic clamp (S1 Fig). This result
supports the hypothesis of a decrease of counterregulatory response to hypoglycemia and
impairment to recognize it (HAAF concept), but we cannot exclude that could be at least par-
tially due to a decrease in handling stress response. However, we were surprised not to detect
any retinal cell death and Caspase3 activation after recurrent hypoglycemic events. This could
be partially explained by an increase in the level of lactate, acting as a neuronal energy source
[31] and as a “metabolic regulator” [32]. In fact, both glucose and lactate metabolism adapt
during recurrent hypoglycemia and this will preserve normal neuron functions under hypogly-
cemia [32]. Moreover, lactate could directly enter the Krebs cycle and prevent glutamate, gluta-
mine, and GABA depletion that occur during hypoglycemia or aglycemia [14]. The restoration
of “normal” GSH level could partially be explained by the presence of these compounds essen-
tial for GSH synthesis; in addition, production of NADPH, which is rate limiting for glutathi-
one reductase activity, could be responsible for the GSH level we observed in recurrent
hypoglycemia. We also observed that both Gpx3 and Gsto1 enzymes, which were up-regulated
during a single hypoglycemic clamp, were indeed down-regulated (Gpx3) or not changed
(Gsto1) during recurrent hypoglycemia (Fig 6). The absence of retinal cell death during recur-
rent hypoglycemia does not per se a demonstration that hypoglycemic events are harmless or
that strict glycemia control could be neglected, because the model of recurrent hypoglycemia,
used in this study, may not strictly reflect what occurs in diabetic patients during HAAF.
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We hypothesized, however, that GSH level is the key element in the prevention of hypogly-
cemia-induced retinal cell death; low level of GSH will increase the risk of apoptosis, while
“normal” level will prevent cell death. This is supported by numerous studies performed in the
brain [33] and by our previous experiments performed on 661W photoreceptor cells where the
decrease of GSH level, by buthionine sulphoximine (BSO), induced cell death, while restoration
of GSH level at low glucose, by GSH ethyl ester, prevented cell death [3]. Treatment with anti-
oxidants, to prevent GSH depletion, may represent an important therapeutic axis to protect
retinal cell death in diabetic patients suffering hypoglycemic events.
Supporting Information
S1 ARRIVE Guidelines Checklist. NC3Rs ARRIVE Guidelines Checklist.
(PDF)
S1 Fig. Glucose infusion (GINF) necessary to maintain hypoglycemia during clamps. Com-
parison of glucose infusion during hyperinsulinemic/hypoglycemic clamps. (circles for mHypo
and square for sHypo). We clearly see an increase of glucose infusion in clamp 2 and 3
(mHypo) in order to maintain hypoglycemia around 2.2 to 2.4mM.
(TIF)
S2 Fig. PCR analysis showing the low level of possible cross-contamination of retinal
mRNA with lens mRNA. Upper panel showed amplification of Crystallin gamma A (Cryga)
from two samples of lens mRNA and from retinal mRNA used for microarray analysis; mRNA
with no reverse transcriptase (RT-) was used as negative control. We used Gapdh amplification
to normalize. Quantitative PCR was performed with these samples in order to quantify the pos-
sible level of cross-contamination. Amplification of Cryga was performed using specific Bio-
Rad primers (#10025636) while normalization with Gapdh was performed using the following
primers (forward: 5'-GAG GCC GGT GCT GAG TAT GT-3' and reverse 5'-GGT GGC AGT
GAT GGC ATG GA-3). Standard conditions was used for PCR analysis with annealing at
60°C.
(TIF)
S1 Table. Experiments performed and mice utilisation during single clamp experiment.
(TIF)
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